Recent changes in cancer care in India show an increase in immunotherapy prescriptions due to affordable biosimilars. Doctors report that the availability of cheaper versions of nivolumab has improved patient access to treatment. Research indicates that lower doses may be effective for Indian patients, contributing to the affordability of therapy. Although progress has been made, significant challenges remain regarding drug availability and hospital practices.
Related Posts
Pune businessman’s son pushed into gorge: How fiancée allegedly tried to pass it off as accident
A trek to Lohagad Fort, initially thought to be a tragic accident, has been revealed as a murder. Police arrested…
Taxpayers alert! Weak rupee may push foreign assets above Rs 1cr, raising tax bill
In fact, the rupee’s decline over the years, strict valuation requirements and the fact that many amounts exceed the prescribed…
‘MPs sleeping’: Delhi transport bodies to march to Parliament on Aug 4 against E20 fuel
Delhi transport groups will march to Parliament on August 4. They demand the withdrawal of ethanol-blended petrol from the market.…